Oral Antidiabetic Agents Market Report

China Oral Antidiabetic Agents Industry Market Research Report 2023-2029

  • POSTDATE：Aug 24, 2023
  • PAGES：137
  • REPORT CODE：GMM1753625
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oral Antidiabetic Agents industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • AstraZeneca

    • Teva

    • Eli Lilly

    • Novo Nordisk

    • Roche

    • Sanofi

    • Wockhardt UK

    • Cipla

    By Type:

    • Biguanides

    • Sulfonylureas

    • Alpha-glucosidase Inhibitors

    • Thiazolidinediones

    • Meglitinides

    By Application:

    • Medical Institutions

    • Home Use

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oral Antidiabetic Agents Market Overview 2018-2029

    • 1.1 China Oral Antidiabetic Agents Industry Development Overview

    • 1.2 China Oral Antidiabetic Agents Industry Development History

    • 1.3 China Oral Antidiabetic Agents Industry Market Size (2018-2029)

    • 1.4 China Oral Antidiabetic Agents Market Analysis by Type from Production Side

      • 1.4.1 China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Biguanides (2018-2029)

      • 1.4.2 China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

      • 1.4.3 China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Alpha-glucosidase Inhibitors (2018-2029)

      • 1.4.4 China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Thiazolidinediones (2018-2029)

      • 1.4.5 China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

    • 1.5 China Oral Antidiabetic Agents Market Analysis by Application from Consumption End

      • 1.5.1 China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Medical Institutions (2018-2029)

      • 1.5.2 China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)

      • 1.5.3 China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Oral Antidiabetic Agents Market Analysis by Region

      • 1.6.1 North China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oral Antidiabetic Agents Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oral Antidiabetic Agents Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oral Antidiabetic Agents Market Status and Competition Analysis in 2023

      • 2.2.3 China Oral Antidiabetic Agents Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oral Antidiabetic Agents Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oral Antidiabetic Agents Industry Development

    Chapter 3 Oral Antidiabetic AgentsIndustry Chain Analysis

    • 3.1 Oral Antidiabetic Agents Industry Chain

    • 3.2 Oral Antidiabetic Agents Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oral Antidiabetic Agents Market

    • 3.3 Oral Antidiabetic Agents Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oral Antidiabetic Agents Market

    Chapter 4 China Oral Antidiabetic Agents Market, by Type

    • 4.1 China Oral Antidiabetic Agents Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oral Antidiabetic Agents Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oral Antidiabetic Agents Production Volume and Growth Rate, by Type

      • 4.5.1 China Oral Antidiabetic Agents Production Volume and Growth Rate of Biguanides

      • 4.5.2 China Oral Antidiabetic Agents Production Volume and Growth Rate of Sulfonylureas

      • 4.5.3 China Oral Antidiabetic Agents Production Volume and Growth Rate of Alpha-glucosidase Inhibitors

      • 4.5.4 China Oral Antidiabetic Agents Production Volume and Growth Rate of Thiazolidinediones

      • 4.5.5 China Oral Antidiabetic Agents Production Volume and Growth Rate of Meglitinides

    Chapter 5 China Oral Antidiabetic Agents Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oral Antidiabetic Agents Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oral Antidiabetic Agents Market Size and Growth Rate, by Application

      • 5.5.1 China Oral Antidiabetic Agents Market Size and Growth Rate of Medical Institutions

      • 5.5.2 China Oral Antidiabetic Agents Market Size and Growth Rate of Home Use

      • 5.5.3 China Oral Antidiabetic Agents Market Size and Growth Rate of Others

    Chapter 6 China Oral Antidiabetic Agents Market, by Region

    • 6.1 China Oral Antidiabetic Agents Production Volume and Production Value, by Region

    • 6.2 China Oral Antidiabetic Agents Sales Volume and Sales Value, by Region

    Chapter 7 North China Oral Antidiabetic Agents Market Analysis

    • 7.1 North China Oral Antidiabetic Agents Market, by Type

    • 7.2 North China Oral Antidiabetic Agents Market, by Application

    Chapter 8 Central China Oral Antidiabetic Agents Market Analysis

    • 8.1 Central China Oral Antidiabetic Agents Market, by Type

    • 8.2 Central China Oral Antidiabetic Agents Market, by Application

    Chapter 9 South China Oral Antidiabetic Agents Market Analysis

    • 9.1 South China Oral Antidiabetic Agents Market, by Type

    • 9.2 South China Oral Antidiabetic Agents Market, by Application

    Chapter 10 East China Oral Antidiabetic Agents Market Analysis

    • 10.1 East China Oral Antidiabetic Agents Market, by Type

    • 10.2 East China Oral Antidiabetic Agents Market, by Application

    Chapter 11 Northeast China Oral Antidiabetic Agents Market Analysis

    • 11.1 Northeast China Oral Antidiabetic Agents Market, by Type

    • 11.2 Northeast China Oral Antidiabetic Agents Market, by Application

    Chapter 12 Southwest China Oral Antidiabetic Agents Market Analysis

    • 12.1 Southwest China Oral Antidiabetic Agents Market, by Type

    • 12.2 Southwest China Oral Antidiabetic Agents Market, by Application

    Chapter 13 Northwest China Oral Antidiabetic Agents Market Analysis

    • 13.1 Northwest China Oral Antidiabetic Agents Market, by Type

    • 13.2 Northwest China Oral Antidiabetic Agents Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Oral Antidiabetic Agents Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 AstraZeneca

        • 14.2.1 AstraZeneca Company Profile

        • 14.2.2 AstraZeneca Oral Antidiabetic Agents Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Teva

        • 14.3.1 Teva Company Profile

        • 14.3.2 Teva Oral Antidiabetic Agents Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eli Lilly

        • 14.4.1 Eli Lilly Company Profile

        • 14.4.2 Eli Lilly Oral Antidiabetic Agents Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Novo Nordisk

        • 14.5.1 Novo Nordisk Company Profile

        • 14.5.2 Novo Nordisk Oral Antidiabetic Agents Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Roche

        • 14.6.1 Roche Company Profile

        • 14.6.2 Roche Oral Antidiabetic Agents Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi

        • 14.7.1 Sanofi Company Profile

        • 14.7.2 Sanofi Oral Antidiabetic Agents Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Wockhardt UK

        • 14.8.1 Wockhardt UK Company Profile

        • 14.8.2 Wockhardt UK Oral Antidiabetic Agents Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Cipla

        • 14.9.1 Cipla Company Profile

        • 14.9.2 Cipla Oral Antidiabetic Agents Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oral Antidiabetic Agents Industry Research Conclusions

    • 15.2 Oral Antidiabetic Agents Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oral Antidiabetic Agents Industry Market Size (2018-2029)

    • Figure China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Biguanides (2018-2029)

    • Figure China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Sulfonylureas (2018-2029)

    • Figure China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Alpha-glucosidase Inhibitors (2018-2029)

    • Figure China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Thiazolidinediones (2018-2029)

    • Figure China Oral Antidiabetic Agents Production Volume, Production Value and Growth Rate of Meglitinides (2018-2029)

    • Figure China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Medical Institutions (2018-2029)

    • Figure China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Home Use (2018-2029)

    • Figure China Oral Antidiabetic Agents Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure Central China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure South China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure East China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oral Antidiabetic Agents Market Size and Growth Rate from 2018-2029

    • Figure Oral Antidiabetic Agents Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oral Antidiabetic Agents Market Share by Type in 2018

    • Figure China Oral Antidiabetic Agents Market Share by Type in 2023

    • Figure China Oral Antidiabetic Agents Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume and Growth Rate of Biguanides (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume and Growth Rate of Sulfonylureas (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume and Growth Rate of Alpha-glucosidase Inhibitors (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume and Growth Rate of Thiazolidinediones (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume and Growth Rate of Meglitinides (2018-2023)

    • Figure China Oral Antidiabetic Agents Market Share by Application in 2018

    • Figure China Oral Antidiabetic Agents Market Share by Application in 2023

    • Figure China Oral Antidiabetic Agents Total Market Size and Growth Rate from Consumption End

    • Figure China Oral Antidiabetic Agents Market Size and Growth Rate of Medical Institutions (2018-2023)

    • Figure China Oral Antidiabetic Agents Market Size and Growth Rate of Home Use (2018-2023)

    • Figure China Oral Antidiabetic Agents Market Size and Growth Rate of Others (2018-2023)

    • Table China Oral Antidiabetic Agents Production Volume by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Production Volume Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Volume Share by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Production Value by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Production Value Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Agents Production Value Share by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Sales Volume by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Sales Volume Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Agents Sales Volume Share by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Sales Value by Region (2018-2023)

    • Table China Oral Antidiabetic Agents Sales Value Share by Region (2018-2023)

    • Figure China Oral Antidiabetic Agents Sales Value Share by Region (2018-2023)

    • Table North China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table North China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure North China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table North China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table North China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure North China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table Central China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table Central China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure Central China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table Central China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table Central China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure Central China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table South China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table South China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure South China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table South China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table South China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure South China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table East China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table East China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure East China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table East China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table East China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure East China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table Northeast China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table Northeast China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table Northeast China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table Southwest China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table Southwest China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table Southwest China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oral Antidiabetic Agents Production Volume by Type (2018-2023)

    • Table Northwest China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oral Antidiabetic Agents Production Volume Share by Type (2018-2023)

    • Table Northwest China Oral Antidiabetic Agents Sales Volume by Application (2018-2023)

    • Table Northwest China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oral Antidiabetic Agents Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Wockhardt UK Company Profile

    • Table Wockhardt UK Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)

    • Table Cipla Company Profile

    • Table Cipla Oral Antidiabetic Agents Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US